ImageneBio Inc
39 hedge funds and large institutions have $86.2M invested in ImageneBio Inc in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
24% more capital invested
Capital invested by funds: $69.8M → $86.2M (+$16.4M)
18% more funds holding
Funds holding: 33 → 39 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.44% less ownership
Funds ownership: 72.35% → 68.91% (-3.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$2.55M |
| 2 |
O
OrbiMed
New York
|
+$966K |
| 3 |
Millennium Management
New York
|
+$378K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$152K |
| 5 |
Jane Street
New York
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$7.56M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.57M |
| 3 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$372K |
| 4 |
E
Ergoteles
New York
|
-$46.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$39.7K |
IMA Hedge Fund Activity: Q1 2023 in Review
39 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2023, worth a combined $86.2M — up 24% from $69.8M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IMA positions and 2 closed out — a net gain of 6 holders — while 14 added to existing stakes and 6 trimmed.
The largest buyer was BVF Inc, adding an estimated $2.55M. The largest seller was Citadel Advisors, cutting an estimated $7.56M.
- 39 institutional investors held ImageneBio Inc (IMA) as of Q1 2023, up from 33 in Q4 2022.
- Funds reported $86.2M of ImageneBio Inc stock for Q1 2023, up 24% quarter-over-quarter.
- 8 funds opened new ImageneBio Inc positions in Q1 2023 and 2 closed out, a net change of +6 holders.
- The largest ImageneBio Inc buyer in Q1 2023 was BVF Inc, an estimated $2.55M added.
- The largest ImageneBio Inc seller in Q1 2023 was Citadel Advisors, an estimated $7.56M sold.
Based on aggregated 13F filings for Q1 2023.